ZVRA Earnings
Latest Revenue39.7M
Latest Net Income8.8M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.14 | 39.7M | 8.8M | +53.3% | -88.7% |
| Q1 2026 | $0.62 | 36.2M | 37.9M | +77.5% | +1,133.3% |
| Q4 2025 | $0.22 | 34.1M | 12.2M | +183.4% | +132.8% |
| Q3 2025 | -$0.01 | 26.1M | -544000 | +605.4% | +98.6% |
| Q2 2025 | $1.24 | 25.9M | 74.7M | +481.7% | +358.3% |
| Q1 2025 | -$0.06 | 20.4M | -3099000 | +495.6% | +85.0% |
| Q4 2024 | -$0.67 | 12.0M | -35739000 | -6.8% | -31.4% |
| Q3 2024 | -$0.69 | 3.7M | -33225000 | +27.6% | -130.0% |
| Q2 2024 | -$0.48 | 4.4M | -19925000 | — | — |
| Q1 2024 | -$0.40 | 3.4M | -16622000 | — | — |
| Q4 2023 | -$0.51 | 12.9M | -19892000 | — | — |
| Q3 2023 | -$0.30 | 2.9M | -10367000 | — | — |
Zevra Therapeutics (ZVRA) — Earnings